EW241220C85000
- 0.11
- +0.06+120.00%
Edwards Lifesciences Newsroom
Edwards Lifesciences Analyst Ratings
Citi Maintains Edwards Lifesciences(EW.US) With Buy Rating, Raises Target Price to $83
Truist Financial Maintains Edwards Lifesciences(EW.US) With Hold Rating, Maintains Target Price $78
Edwards Lifesciences (EW) Receives a Hold From Truist Financial
A Quick Look at Today's Ratings for Edwards Lifesciences(EW.US), With a Forecast Between $75 to $90
Oppenheimer Remains a Buy on Edwards Lifesciences (EW)
Edwards Lifesciences (EW) Receives a Buy From RBC Capital
Bank of America Securities Keeps Their Hold Rating on Edwards Lifesciences (EW)
Goldman Sachs Maintains Buy on Edwards Lifesciences, Raises Price Target to $90
Hold Rating for Edwards Lifesciences: Balancing Risks and Opportunities Amidst Market Variability
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Evolent Health (EVH) and Palisade Bio (PALI)
UBS Adjusts Price Target on Edwards Lifesciences to $78 From $75, Keeps Neutral Rating
Edwards Lifesciences Is Maintained at Hold by Canaccord Genuity
Edwards Lifesciences Analyst Ratings
Leerink Adjusts Price Target on Edwards Lifesciences to $74 From $73
Barclays Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $88
Edwards Lifesciences Price Target Raised to $88.00/Share From $85.00 by Barclays
Barclays Maintains Edwards Lifesciences(EW.US) With Buy Rating, Raises Target Price to $88
Wells Fargo Maintains Edwards Lifesciences(EW.US) With Buy Rating, Maintains Target Price $80
Edwards Lifesciences (EW) Receives a Hold From Leerink Partners